Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunedin Ent.it. Regulatory News (DNE)

  • This share is currently suspended. It was suspended at a price of 470.00

Share Price Information for Dunedin Ent.it. (DNE)

Share Price is delayed by 15 minutes
Get Live Data
470.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
DNE Live PriceLast checked at - London Stock Exchange

Intraday Dunedin Ent.it. Share Chart

Interim Management Statement

17 May 2010 15:36

RNS Number : 0618M
Dunedin Enterprise Inv Trust PLC
17 May 2010
 

Dunedin Enterprise Investment Trust PLC (Company No SC52844) - Interim Management Statement

Dunedin Enterprise Investment Trust PLC ("Dunedin Enterprise") presents its Interim Management Statement for the quarter ended 31 March 2010. This is the Company's first interim management statement for the financial year ending 31 December 2010, as required by the FSA Disclosure and Transparency Rule 4.3.

 

1. Investment Objective

 

Dunedin Enterprise specialises in the provision of private equity finance. Private equity is medium to long term finance provided in return for an equity stake in established, potentially high growth private companies. The Company's investment objective is to achieve substantial long term capital growth in its assets through capital gains from its investments.

 

2. Unaudited net asset value per share

 

The unaudited net asset value per share at 31 March 2010 was 422.5p. This represents an increase of 3.8% from the level at 31 December 2009.

 

3. Share price and discount

 

The share price rose by 7.4% from 266.5p to 286.3p in the quarter to 31 March 2010. This compares to a rise in the FTSE Small Cap Index of 1.1% over the same period.

 

Based upon the net asset value per share of 422.5p, the discount of the share price to the net asset value per share decreased from 34.5% to 32.2% in the quarter. When cash is excluded from net assets then the discount increases to 55.0%.

 

The share price at the close of business on 14 April 2010 was 268p, which was 0.6% higher than at 31 December 2009. The share price of 268p represents a discount of 36.6% to the net asset value per share of 422.5p and when cash is excluded from net assets then the discount increases to 62.3%.

 

4. Balance Sheet

 

The balance sheet as at 31 March 2010 is noted below:-

 

£m

Investments:-

Dunedin managed 37.9

Third party managed 6.7

Listed private equity 28.4

Legacy technology funds 1.9

74.9

Cash and near cash 52.7

Other assets/liabilities (0.1)

Total net assets 127.5

 

Net asset value per share (p) 422.5

 

 

5. Valuations

 

The portfolio of investments has been revalued at 31 March 2010. The most significant movements in net asset during the quarter were a result of:-

·; an increase in the value of Euro listed private equity of £2.4m,

·; an increase in price earnings multiples generating a £1.7m uplift in Dunedin managed investments,

·; an uplift of £1.4m from Third party funds generated from a realisation by LGV3 (£0.8m) and valuation increases at Realza (£0.5m),

·; payment of the interim dividend -£0.6m, and

·; other movements of -£0.3m.

 

6. Commitments

 

As at 31 March 2010 the Company has outstanding capital commitments to limited partnership funds of £105.7m. In addition to cash and near cash balances of £52.7m at 31 March 2010 the Company has listed private equity of £28.4m.

 

The Company's unutilised revolving credit facility expired on 29 April 2010 and has not been replaced.

 

7. Outlook

 

We continue to work with our portfolio companies to protect and enhance value. The environment for new investment remains uncertain but recent events in the markets have created increased opportunities for transactions.

 

 

For further information on Dunedin Enterprise please go to www.dunedin.com

 

ENDS

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBSGDUXXBBGGR
Date   Source Headline
30th Nov 202212:10 pmRNSHolding(s) in Company
29th Nov 20225:25 pmRNSHolding(s) in Company
29th Nov 202210:42 amRNSHolding(s) in Company
28th Nov 20229:06 amRNSHolding(s) in Company
25th Nov 20222:32 pmRNSHolding(s) in Company
22nd Nov 20227:00 amRNSResult of Tender Offer
16th Nov 202212:52 pmRNS3rd Quarter Results
16th Nov 202212:49 pmRNSResult of General Meeting
4th Nov 202210:00 amRNSHolding(s) in Company
4th Nov 20228:51 amRNSHolding(s) in Company
1st Nov 20227:00 amRNSQ3 Preliminary NAV and Tender Offer Price
21st Oct 20227:00 amRNSInterim Dividend
21st Oct 20227:00 amRNSTender Offer
7th Oct 20227:00 amRNSPortfolio Update
16th Sep 20227:00 amRNSHalf-year Report
25th Aug 20229:15 amRNSPortfolio Update
1st Aug 20227:00 amRNSPreliminary unaudited net asset value at 30/6/22
11th May 20222:58 pmRNSResult of AGM
11th May 20221:26 pmRNS1st Quarter Results
3rd May 20227:00 amRNSPreliminary unaudited net asset value at 31/3/22
13th Apr 202210:47 amRNSDirector/PDMR Shareholding
21st Mar 202212:43 pmRNSPortfolio Update
18th Mar 20227:00 amRNSAnnual Financial Report
2nd Mar 202212:41 pmRNSHolding(s) in Company
11th Feb 20227:00 amRNSDividend Declaration
1st Feb 20227:00 amRNSPreliminary Unaudited Net Asset Value at 31/12/21
16th Dec 20213:28 pmRNSDirector/PDMR Shareholding
15th Dec 20217:00 amRNSPortfolio Update
8th Dec 202110:05 amRNSListing Rule 9.6.14
1st Dec 202110:02 amRNSDirector/PDMR Shareholding
1st Dec 202110:01 amRNSDirector/PDMR Shareholding
26th Nov 202112:45 pmRNSDirector/PDMR Shareholding
26th Nov 202112:44 pmRNSDirector/PDMR Shareholding
26th Nov 202112:42 pmRNSDirector/PDMR Shareholding
24th Nov 20217:56 amRNSDirector/PDMR Shareholding
24th Nov 20217:54 amRNSDirector/PDMR Shareholding
24th Nov 20217:46 amRNSHolding(s) in Company
19th Nov 20218:18 amRNSHolding(s) in Company
19th Nov 20217:00 amRNS3rd Quarter Results
16th Nov 20217:00 amRNSResult of Tender Offer
10th Nov 202111:43 amRNSResult of General Meeting
1st Nov 20217:00 amRNSQ3 Preliminary NAV and Tender Offer Price
18th Oct 20219:20 amRNSTender Offer
13th Oct 202110:00 amRNSPortfolio Update
6th Oct 20217:00 amRNSDividend Declaration
21st Sep 202110:00 amRNSCapital Reorganisation
16th Sep 20217:00 amRNSHalf-year Report
2nd Aug 20217:00 amRNSPreliminary Unaudited Net Asset Value at 30/6/21
30th Jul 202112:25 pmRNSCapital Reorganisation
7th Jul 20211:13 pmRNSPortfolio Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.